Investor Relations

OPKO and Pfizer Enter into Global Agreement for OPKO's Long-Acting Human Growth Hormone (hGH-CTP) more »

OPKO Health to Present at the Oppenheimer 25th Annual Healthcare Conference more »

OPKO Health to Present at the Jefferies 2014 Global Healthcare Conference more »

OPKO Announces Publication of Large, Prospective, Multi-Institutional Clinical Validation of the 4Kscore™ Test for High Grade Prostate Cancer in the United States more »

Investor Relations

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put OPKO Health, Inc.'s financial performance into perspective.

  • Events


  • Stock Information


Ticker OPK Exchange NYSE
Last Price 9.60 Change 0.14 up
Open 9.46 Previous Close 9.46
Day High 9.64 Day Low 9.36
52-Week High 10.25 52-Week Low 7.32
Quotes delayed at least 20 minutes. Information provided by eSignal.